e-Edition
Obituaries
Special Sections
Special Occasions
Contact

Subscribe
Paywall Login
Login to Comment
Register

December 11th, 2017

jobs

homes

Home
News
Sports
Business
Entertainment
Classifieds
Commentary

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

CervoMed Inc. - Common Stock (NQ:CRVO)

4.085 +0.095 (+2.38%)

Streaming Delayed Price Updated: 1:46 PM EDT, Apr 17, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about CervoMed Inc. - Common Stock

< Previous 1 2 3 Next >

CervoMed’s neflamapimod elected for inclusion in UK EXPERTS-ALS platform designed to prioritize promising treatments for Amyotrophic Lateral Sclerosis

February 18, 2026

From CervoMed Inc.

Via GlobeNewswire

This Docebo Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Wednesday ↗

November 05, 2025

Via Benzinga

This Trex Company Analyst Turns Bearish; Here Are Top 5 Downgrades For Wednesday ↗

November 05, 2025

Via Benzinga

This Sarepta Therapeutics Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday ↗

November 05, 2025

Via Benzinga

CervoMed Gets $11 Price Target From HC Wainwright, Analyst Says Regulatory Outlook For Experimental Dementia Drug Should Be Clear Soon ↗

September 08, 2025

Via Stocktwits

CervoMed Drug Cut Dementia Progression Risk By 75% In Trial ↗

October 08, 2025

CervoMed's Phase 2b trial shows neflamapimod reduces dementia progression and plasma GFAP, with significant cognitive improvements in Lewy body dementia patients.

Via Benzinga

Peraso (NASDAQ: PRSO) Powers Military, Nex-Gen Broadband Surge – Mag 7 Undercard VAPE CELC, CRVO – More Stocks Inside

July 28, 2025

Via AB Newswire

Topics Supply Chain

CervoMed Dementia Drug Slows Disease Progression In Study: Retail Loads Up On The Stock ↗

July 28, 2025

The company is now poised to initiate late-stage trials for Neflamapimod.

Via Stocktwits

CervoMed's Dementia Data Show Slowed Disease Progression ↗

July 28, 2025

CervoMed reports 32-week data showing neflamapimod slowed DLB progression and reduced neurodegeneration biomarkers with good tolerability.

Via Benzinga

Traders are paying attention to the gapping stocks in Monday's session. ↗

July 28, 2025

Traders are paying attention to the gapping stocks in Monday's session. Let's dive into which stocks are experiencing notable gaps.

Via Chartmill

What's going on in today's pre-market session ↗

July 28, 2025

Discover the top movers in Monday's pre-market session and stay informed about market dynamics.

Via Chartmill

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

July 28, 2025

Via Benzinga

11 Health Care Stocks Moving In Thursday's Intraday Session ↗

April 03, 2025

Via Benzinga

EXCLUSIVE: March's 20 Most-Searched Tickers On Benzinga Pro — Where Do Tesla, Nvidia, Apple, Applovin Stock Rank? ↗

April 01, 2025

A look at the top 20 most-searched stocks on Benzinga Pro in March. While many had news in the month that could affect rankings, the trends could be a sign of what's to come.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

March 27, 2025

Via Benzinga

Keep an eye on the top gainers and losers in Wednesday's session. ↗

March 26, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

March 26, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

March 24, 2025

Via Benzinga

Traders are paying attention to the gapping stocks in Monday's session. ↗

March 24, 2025

Traders are paying attention to the gapping stocks in Monday's session. Let's dive into which stocks are experiencing notable gaps.

Via Chartmill

12 Health Care Stocks Moving In Friday's Intraday Session ↗

March 21, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

March 20, 2025

Via Benzinga

Peering Into CervoMed's Recent Short Interest ↗

March 17, 2025

Via Benzinga

On Monday, there are stocks with unusual volume. Let's take a look. ↗

March 17, 2025

On Monday, there are stocks with unusual volume. Let's take a look.

Via Chartmill

12 Health Care Stocks Moving In Monday's Intraday Session ↗

March 17, 2025

Via Benzinga

On Friday, there are stocks with unusual volume. Let's take a look. ↗

March 14, 2025

Let's have a look at what is happening on the US markets on Friday. Below you can find the stocks with an unusual volume in today's session.

Via Chartmill

Unusual volume stocks in Thursday's session ↗

March 13, 2025

Let's have a look at what is happening on the US markets on Thursday. Below you can find the stocks with an unusual volume in today's session.

Via Chartmill

CervoMed's Dementia Study's 16-Week Data 'Compelling Enough To Move From Sidelines' Analyst Says ↗

March 13, 2025

CervoMed's Phase 2b study extension shows improved cognitive outcomes with neflamapimod, leading to an analyst upgrade and increased confidence in the drug.

Via Benzinga

Top movers in Thursday's pre-market session ↗

March 13, 2025

Let's have a look at what is happening on the US markets before the opening bell on Thursday. Below you can find the top gainers and losers in today's pre-market session.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

March 13, 2025

Via Benzinga

This Wells Fargo Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday ↗

March 13, 2025

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

More ways to get to us

Facebook

Twitter

YouTube

ePaper Login
Subscribe
Subscription Services
Archive

About Us

The Lethbridge Herald
Other Publications
Food For Thought

Contact
Careers

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

Advertising
Terms and Conditions & Privacy Policy